Transient Receptor Potential Channels and Retinal Ganglion Cell Death in Glaucoma

青光眼中的瞬时受体电位通道和视网膜神经节细胞死亡

基本信息

  • 批准号:
    7870313
  • 负责人:
  • 金额:
    $ 30.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-07-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term objective is to understand the early molecular events leading to the death of retinal ganglion cells (RGCs) and their axons in glaucoma. The defining feature of glaucoma is sensitivity to intraocular pressure (IOP), and elevated IOP represents a significant risk factor for the disease. Lowering IOP pharmacologically is the standard treatment to slow the disease, but there is no cure because the neurobiological mechanisms linking RGC degeneration to pressure remain unresolved. The death of RGCs in glaucoma demonstrates key aspects of neuronal death in other degenerative diseases, most prominently somatic (cell body) loss via apoptosis and axonal degeneration. In other diseases, somatic and axonal degenerative are often linked to elevated intracellular Ca2+, and Ca2+-dependent cascades are also likely to contribute to RGC degeneration in glaucoma. Our studies demonstrate that for RGCs exposed to elevated pressure in culture, rapidly increased intracellular Ca2+ predicates both somatic and axonal loss. These observations raise the questions of whether pressure-induced RGC death is dependent on increased intracellular Ca2+ and, if so, what is the mechanism of this dependence. We have hypothesized that pressure-induced RGC degeneration involves the activation of a mechanosensitive channel that directly gates an increase in intracellular Ca2+. In support of this hypothesis, we recently identified in RGCs the capsaicin-sensitive, vanilloid-1 transient receptor potential (TRPV1) channel. TRPV1 is characterized by a robust Ca2+ conductance that contributes to pressure sensitivity and Ca2+-dependent cell death in other systems. Here we will probe the relationships between pressure-induced changes in intracellular Ca2+, RGC death and TRPV1 activation using an in vitro preparation of purified RGCs optimized for studying somatic degeneration and a retinal explant preparation optimized for studying axonal degeneration ex vivo. By applying pharmacological tools to these systems we will (1) test the Ca2+-dependence of pressure-induced RGC degeneration and the contribution of TRPV1 to pressure-induced increases in RGC intracellular Ca2+ and (2) determine the dependence of pressure-induced RGC degeneration on TRPV1 activation. Finally, by applying genetic tools for gene inhibition and over-expression developed in our laboratory and a TRPV1 knock-out mouse we will (3) test the relationship between TRPV1 expression and RGC susceptibility to pressure-induced degeneration. PUBLIC HEALTH RELEVANCE:. With the aging of the population, glaucoma will afflict nearly 80 million people worldwide by 2020, making the disease the leading cause of irreversible blindness. Glaucoma remains incurable, largely because our understanding of how pressure sensitivity translates to RGC degeneration is incomplete. The work proposed here will explore a viable molecular mechanism for contributing to RGC susceptibility to pressure-related injury and test its relevance as a novel therapeutic target.
描述(由申请人提供):我们的长期目标是了解导致青光眼中视网膜神经节细胞(RGC)及其轴突死亡的早期分子事件。青光眼的定义特征是对眼内压(IOP)的敏感性,并且IOP升高代表该疾病的显著危险因素。降低眼压是减缓疾病的标准治疗方法,但由于将RGC变性与压力联系起来的神经生物学机制尚未解决,因此无法治愈。青光眼中RGC的死亡证明了其他退行性疾病中神经元死亡的关键方面,最显著的是通过细胞凋亡和轴突变性的体细胞(细胞体)损失。在其他疾病中,体细胞和轴突变性通常与细胞内Ca 2+升高有关,Ca 2+依赖性级联也可能导致青光眼中的RGC变性。我们的研究表明,对于暴露于培养中的高压的RGCs,细胞内Ca 2+的迅速增加预示着体细胞和轴突的损失。这些观察结果提出了一个问题,是否压力诱导的RGC死亡是依赖于细胞内Ca 2+的增加,如果是这样,这种依赖的机制是什么。我们假设压力诱导的RGC变性涉及直接门控细胞内Ca 2+增加的机械敏感性通道的激活。为了支持这一假设,我们最近在RGCs中发现了辣椒素敏感的香草素-1瞬时受体电位(TRPV 1)通道。TRPV 1的特征在于强大的Ca 2+电导,这有助于其他系统中的压力敏感性和Ca 2+依赖性细胞死亡。在这里,我们将探讨压力诱导的细胞内Ca 2+,RGC死亡和TRPV 1激活的变化之间的关系,使用体外制备的纯化RGC优化研究体细胞变性和视网膜外植体制备优化研究轴突变性离体。通过将药理学工具应用于这些系统,我们将(1)测试压力诱导的RGC变性的Ca 2+依赖性和TRPV 1对压力诱导的RGC细胞内Ca 2+增加的贡献,以及(2)确定压力诱导的RGC变性对TRPV 1激活的依赖性。最后,通过应用我们实验室开发的基因抑制和过表达的遗传工具和TRPV 1敲除小鼠,我们将(3)测试TRPV 1表达与RGC对压力诱导的变性的易感性之间的关系。公共卫生相关性:随着人口老龄化,到2020年,青光眼将困扰全球近8000万人,使该疾病成为不可逆失明的主要原因。青光眼仍然无法治愈,主要是因为我们对压力敏感性如何转化为RGC变性的理解不完整。本文提出的工作将探索一种可行的分子机制,有助于RGC对压力相关损伤的易感性,并测试其作为新的治疗靶点的相关性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David J. Calkins其他文献

Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
青光眼神经退行性变的研究:机制、挑战与治疗
  • DOI:
    10.1016/j.preteyeres.2024.101261
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
    14.700
  • 作者:
    Ghazi O. Bou Ghanem;Lauren K. Wareham;David J. Calkins
  • 通讯作者:
    David J. Calkins
M and L cones in macaque fovea connect to midget ganglion cells by different numbers of excitatory synapses
猕猴中央凹的 M 和 L 视锥细胞通过不同数量的兴奋性突触连接到侏儒神经节细胞
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    64.8
  • 作者:
    David J. Calkins;S. Schein;Y. Tsukamoto;P. Sterling
  • 通讯作者:
    P. Sterling
OPTIC NERVE REGENERATION IN MAMMALS: REGENERATED OR SPARED
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David J. Calkins
  • 通讯作者:
    David J. Calkins
Ganglion cell circuits in primate fovea
灵长类动物中央凹的神经节细胞回路
  • DOI:
    10.1007/978-94-011-0507-1_32
  • 发表时间:
    1995
  • 期刊:
  • 影响因子:
    13.7
  • 作者:
    David J. Calkins;S. Schein;Y. Tsukamoto;P. Sterling
  • 通讯作者:
    P. Sterling
High-resolution matrix-assisted laser desorption ionization–imaging mass spectrometry of lipids in rodent optic nerve tissue
啮齿动物视神经组织脂质的高分辨率基质辅助激光解吸电离成像质谱分析
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    David M. G. Anderson;Daniel Mills;J. Spraggins;W. Lambert;David J. Calkins;K. Schey
  • 通讯作者:
    K. Schey

David J. Calkins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David J. Calkins', 18)}}的其他基金

Retinal Ganglion Cell Replacement in Optic Neuropathies
视神经病变中的视网膜神经节细胞替代
  • 批准号:
    10239017
  • 财政年份:
    2018
  • 资助金额:
    $ 30.39万
  • 项目类别:
Retinal Ganglion Cell Replacement in Optic Neuropathies
视神经病变中的视网膜神经节细胞替代
  • 批准号:
    10016302
  • 财政年份:
    2018
  • 资助金额:
    $ 30.39万
  • 项目类别:
Mechanisms of Adaptive Remodeling and Their Therapeutic Potential in Glaucoma
适应性重塑机制及其在青光眼中的治疗潜力
  • 批准号:
    10583190
  • 财政年份:
    2014
  • 资助金额:
    $ 30.39万
  • 项目类别:
Mechanisms of Synaptic Remodeling and Neuronal Self-Repair in Aging and Glaucoma
衰老和青光眼中突触重塑和神经元自我修复的机制
  • 批准号:
    9181431
  • 财政年份:
    2014
  • 资助金额:
    $ 30.39万
  • 项目类别:
Mechanisms of Synaptic Remodeling and Neuronal Self-Repair in Aging and Glaucoma
衰老和青光眼中突触重塑和神经元自我修复的机制
  • 批准号:
    8976847
  • 财政年份:
    2014
  • 资助金额:
    $ 30.39万
  • 项目类别:
Role of the Nrf2/ARE pathway in retinal ganglion cells during glaucoma pathogenesis and neuroprotection
Nrf2/ARE 通路在青光眼发病机制和神经保护中视网膜神经节细胞中的作用
  • 批准号:
    10291073
  • 财政年份:
    2012
  • 资助金额:
    $ 30.39万
  • 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
  • 批准号:
    10231186
  • 财政年份:
    2012
  • 资助金额:
    $ 30.39万
  • 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
  • 批准号:
    10414846
  • 财政年份:
    2012
  • 资助金额:
    $ 30.39万
  • 项目类别:
Erythropoietin-mediated antioxidant pathways in glaucoma
青光眼中促红细胞生成素介导的抗氧化途径
  • 批准号:
    9982922
  • 财政年份:
    2012
  • 资助金额:
    $ 30.39万
  • 项目类别:
Transient Receptor Potential Channels and Neurodegeneration in Glaucoma
青光眼的瞬时受体电位通道和神经变性
  • 批准号:
    8708867
  • 财政年份:
    2008
  • 资助金额:
    $ 30.39万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 30.39万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了